Market Tracker

07/06 6:01pm ET

Exelixis Inc (NASDAQ:EXEL)

3.51
Delayed Data
As of Jul 06
 +0.07 / +2.03%
Today’s Change
1.26
Today|||52-Week Range
4.55
+143.75%
Year-to-Date

Today’s Trading

Previous close3.44
Today’s open3.37
Day’s range3.31 - 3.52
Volume2,275,247
Average volume (3 months)3,340,332
Market cap$674.0M
Dividend yield--
Data as of 4:00pm ET, 07/06/2015

Growth & Valuation

Earnings growth (last year)-3.76%
Earnings growth (this year)+41.43%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)-19.87%
P/E ratioNM
Price/Sales11.14
Price/Book--

Competitors

 Today’s
change
Today’s
% change
AMRIAlbany Molecular Res...-0.12-0.60%
SGMOSangamo BioSciences ...+0.08+0.80%
LXRXLexicon Pharmaceutic...+0.51+6.25%
FLXNFlexion Therapeutics...+1.31+6.18%
Data as of 4:00pm ET, 07/06/2015

Financials

Next reporting dateJuly 30, 2015
EPS forecast (this quarter)-$0.21
Annual revenue (last year)$25.1M
Annual profit (last year)-$268.5M
Net profit margin-1,069.42%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Michael M. Morrissey
Chief Financial Officer, Senior VP &
Controller
Deborah Burke
Corporate headquarters
South San Francisco, California

Forecasts